The tumors that developed from sema3F expressing MDA-MB-231 cells (Fig. 3, A–B) looked less bloody than the control tumors suggesting that sema3F may inhibit tumor angiogenesis (Fig. S3, A). This evidence concerns the gene SEMA3F and neoplasm.